Co-Funders Join Merck for Mothers to Support Newly Formed City-Based Coalitions
KENILWORTH, N.J., September 18, 2019 /3BL Media/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today its funding support of projects in nine cities across the country to help end preventable maternal deaths. Each project will be tailored to the needs of pregnant women in their respective city, focusing on reducing barriers to prenatal and postpartum care and addressing both the health and social factors that affect a healthy pregnancy and childbirth.
Merck was recognized on PEOPLE’s third annual 50 Companies That Care list for investing $500 million to reduce preventable maternal mortality across the globe with education, tools and technologies for health care providers and moms through its Merck for Mothers program.
When we invest in maternal health, we ensure that hundreds of thousands of women survive pregnancy and childbirth. When that happens, newborns are more likely to survive, children are more likely to stay in school, women are able to make invaluable contributions to their communities and the workforce, health systems are stronger, and nations’ economies grow. Improved maternal health care sets the foundation for women, children, families, communities, and societies to thrive for generations to come.
OSLO, Norway, June 3, 2019 /3BL Media/ - Dr. Agbor Ashumanyi Ako, one of the co-founders of Business Call to Action member GiftedMom, a digital health platform based in Cameroon that gives pregnant women and mothers across Africa access to vital health information and care, has been awarded the Oslo Business for Peace Award 2019.
Our company provides support to many women’s health initiatives around the world. Through Merck for Mothers, we support programs that reduce maternal mortality and improve access to quality health care for women. In addition, through our Merck Fellowship program, employees share their unique skills to advance health care around the world.
Jhpiego is one of more than 100+ partners in 30 countries with whom the Merck for Mothers initiative partners. Since 2011, the initiative has increased access to quality maternal health care and family planning services for over 7 million women.
by Dr. Mary-Ann Etiebet, Executive Director of Merck for Mothers
Five years ago, Saving Mothers, Giving Life (SMGL) – a major public-private partnership – set the ambitious goal of reducing maternal mortality by half in target districts in Uganda and Zambia, and later Nigeria.
KENILWORTH, N.J., June 27, 2018 /3BL Media/ – Merck (NYSE: MRK), known as MSD outside the United States and Canada, through its Merck for Mothers initiative announced study results on an investigational heat-stable formulation of carbetocin for the prevention of excessive bleeding after childbirth, also known as postpartum haemorrhage (PPH).
by Dr. Neel Shah, Assistant Professor at Harvard Medical School
As an obstetrician, my job is to focus on moms and babies. But one of my favorite parts of childbirth is the look on a new dad’s face at the precise moment he sees his baby for the first time. The physical connection between moms and babies begins sooner and more gradually than it does for dads. Moms feel their babies growing and wriggling months before they get to actually see them. For dads, the first physical connection is visual. Fatherhood goes from being abstract to very real in an instant. And that look is everything.
At Merck for Mothers, we believe that actionable research is essential for taking on maternal mortality. On behalf of our team and many partners, we are pleased to share Evidence for Impact, our first Research Compendium. The publications included in this compendium advance our collective understanding of the problem of maternal mortality, inform the design and implementation of programs aiming to improve women’s health, and strengthen the global health community of practice to save women’s lives.
Merck for Mothers lead Dr. Naveen Rao has announced his intent to retire on July 1. Dr. Rao has led Merck for Mothers since its inception, and was responsible for leveraging Merck's scientific and business expertise to accelerate the program's progress. Dr. Mary-Ann Etiebet, currently the executive director, will succeed Dr. Rao.